Antioxidant enzyme levels in cancer

Area of Science:

• Biochemistry
• Oncology
• Cellular Biology

Background:

• Normal cells utilize antioxidant enzymes to counteract reactive oxygen species (ROS).
• Most cancers exhibit reduced antioxidant enzyme activity, yet some display elevated levels, particularly manganese superoxide dismutase (MnSOD).
• Adenocarcinomas can show increased MnSOD and catalase, indicating varied antioxidant enzyme expression across cancer types.

Purpose of the Study:

• To investigate the role of antioxidant enzymes in cancer genesis and the malignant phenotype.
• To evaluate antioxidant enzyme levels in early cancerous lesions.
• To propose novel cancer therapies based on modulating the cellular redox state.

Main Methods:

• Biochemical analysis of antioxidant enzyme levels in cancer cells.
• Morphologic studies of animal and human cancers.
• Immunohistochemical techniques to assess enzyme levels in early lesions.

Main Results:

• Most human and animal cancers show an imbalance in antioxidant enzyme levels compared to their cells of origin.
• Early cancerous lesions, when examined via immunohistochemistry, typically exhibit low antioxidant enzyme levels.
• Nearly all examined human cancer cell types, except one variant, demonstrated low catalase and glutathione peroxidase, impairing hydrogen peroxide detoxification.

Conclusions:

• Antioxidant enzyme levels are significantly altered in cancer, playing a role in cancer development and progression.
• Immunohistochemistry is crucial for studying enzyme dynamics in early-stage cancers.
• Findings support the development of redox-modulating cancer therapies.